Identification of Matrine as a Novel Regulator of the CXCR4 Signaling Axis in Tumor Cells

Matrine, a quinolizidine alkaloid, is commonly employed for treating various viral and inflammatory disorders. Here, we have evaluated matrine for its activity on C-X-C chemokine receptor type 4 (CXCR4) and matrix metalloproteinases (MMP-9/2) expression, and its potential to affect tumor metastasis...

Descripción completa

Detalles Bibliográficos
Autores principales: Jung, Young Yun, Um, Jae-Young, Narula, Acharan S., Namjoshi, Ojas A., Blough, Bruce E., Kumar, Alan Prem, Ahn, Kwang Seok
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7370290/
https://www.ncbi.nlm.nih.gov/pubmed/32630806
http://dx.doi.org/10.3390/ijms21134731

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7370290/
https://www.ncbi.nlm.nih.gov/pubmed/32630806
http://dx.doi.org/10.3390/ijms21134731

Ejemplares similares